Zhijian Lin

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Early Breast Cancer

Monoclonal Antibody

Top Venues

Drug design, development and therapy

Oxidative medicine and cellular longevity

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Huang, Zhijian Lin, Yu Wang, Xueli Ding, Bing Zhang
Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation. Drug design, development and therapy 17 (2023)
Jing Huang, Zhijian Lin, Yu Wang, Xueli Ding, Bing Zhang
Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation. Drug design, development and therapy 17 (2023)
Xiaoxiong Yang, Yu Wang, Xueli Ding, Shanshan Ju, Xiaoye An, Bing Zhang, Zhijian Lin
Network pharmacology identification and in vivo validation of key pharmacological pathways of Qin Jiao for gout and arthritis. Pharmaceutical biology 61 (1) (2023)
Ayushi Sharma, Anjana Goel, Zhijian Lin
In Vitro and In Silico Anti-Rheumatic Arthritis Activity of Nyctanthes arbor-tristis . Molecules (Basel, Switzerland) 28 (16) (2023)
Zhijian Lin, Muthuvel Jayachandran, Zejfa Haskic, Sanjay Kumar, John C Lieske
Differences of Uric Acid Transporters Carrying Extracellular Vesicles in the Urine from Uric Acid and Calcium Stone Formers and Non-Stone Formers. International journal of molecular sciences 23 (17) (2022)
Yu Wang, Yifei Rao, Zhijian Lin, Rina Sa, Yuling Yin, Xiaomeng Zhang, Bing Zhang
Current Status and Trends of Research on Anthracycline-Induced Cardiotoxicity from 2002 to 2021: A Twenty-Year Bibliometric and Visualization Analysis. Oxidative medicine and cellular longevity 2022 (2022)